MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Effect of PD medication on disease progression as measured by rate of change in MDS_UPDRS and DaT SBR in PPMI study

    J. Cedarbaum, K. Evans, M. Yang, J. Xiao (Cambridge, MA, USA)

    Objective: In clinical trials for new PD therapies, it is common for patients to start to take approved symptomatic PD medications during the study. The…
  • 2018 International Congress

    Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment

    M. Park, D. Kwon (Ansan-city, Korea)

    Objective: We evaluated the screening ability of the Korean version of the Montreal Cognitive Assessment (K-MoCA) in the patients with Parkinson's disease. Background: The Montreal…
  • 2018 International Congress

    Perry syndrome: Proposal of international diagnostic criteria and a new disease concept

    T. Mishima, S. Fujioka, H. Tomiyama, I. Yabe, R. Kurisaki, N. Fujii, R. Neshige, O. Ross, M. Farrer, D. Dickson, Z. Wszolek, N. Hattori, Y. Tsuboi (Fukuoka, Japan)

    Objective: To propose international diagnostic criteria for Perry syndrome and a new disease concept. Background: Perry syndrome is a rare autosomal dominant neurodegenerative disease characterised…
  • 2018 International Congress

    The effects of STN-DBS on the Parkinson’s disease patients with different progressive rates

    R. Qi, H. Yu, J. Li, X. Geng (Kunming, China)

    Objective: The aim of this study is to explore the effects of STN-DBS on the Parkinson's disease patients with different progressive rates Background: Studies indicate…
  • 2018 International Congress

    Clinical effectiveness of a highly challenging balance training (HiBalance program) for Parkinson’s disease: A multi-center clinical effectiveness trial

    B. Leavy, C. Joseph, N. Löfgren, H. Johansson, M. Hagströmer, E. Franzén (Stockholm, Sweden)

    Objective: To determine the effectiveness of the adapted HiBalance program on balance control and gait among people with mild-moderate PD when performed in multiple clinical…
  • 2018 International Congress

    Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 2-year follow-up study of gait parameters

    Z. Guduru, G. Gera, G. Quintero, C. Van Horne, G. Gerhardt (Lexington, KY, USA)

    Objective: Measuring gait parameters in patients with Parkinson's disease (PD) who underwent autologous peripheral nerve grafts implantation (surgical deployment of the Schwann cells obtained from…
  • 2018 International Congress

    Gait disorders in Parkinson’s disease: 19 observations at the University Hospital Center of Conakry

    F. Sakadi, C. Abass, T. Rahamatou, B. Talibé, N. Woga, B. Kenda, C. Amara (Conakry, Guinea)

    Objective: We report the cases in order to make a clinical and evolutionary evaluation of this pathology. Background: Gait disorders are more and more reported…
  • 2018 International Congress

    Effects of Intensive Voice and Articulation Treatments on Voice Quality in Parkinson’s disease

    J. Spielman, L. Ramig, K. Freeman, A. Halpern, Y. Maryn (Denver, CO, USA)

    Objective: This study evaluated the impact of voice treatment (LSVT LOUD) and articulation treatment (LSVT ARTIC) on voice quality in Parkinson's disease (PD) measured by…
  • 2018 International Congress

    The course of Parkinson’s disease in patients with impaired carbohydrate metabolism

    F. Akhmedova, B. Shagazatova, D. Artikova, F. Mirxaydarova (Tashkent, Uzbekistan)

    Objective: To study the state of lipid metabolism in PD patients with concomitant type 2diabetes (with different glucose tolerance and the effect of DA agonist…
  • 2018 International Congress

    A single center retrospective analysis of Opicapone treatment in 90 Parkinson patients

    M. Winterholler, H. Erxleben (Schwarzenbruck, Germany)

    Objective: To evaluate retrospectively the treatment with the novel COMT-inhibitor opicapone (OPC) in a tertiary Parkinson Center the first year after its approval in Germany…
  • « Previous Page
  • 1
  • …
  • 251
  • 252
  • 253
  • 254
  • 255
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23139 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley